While retail prices for cancer drugs may be the highest in the U.S., these medicines appear to be less affordable in poorer countries such as India and China despite their…
A new report out of the UK this week recommends monetary incentives to induce drugmakers to develop vaccines for drug-resistant infections. Source: International Pharmaceutical Regulatory Monitor
The UK’s National Institute for Health and Care Excellence refused to recommend Janssen’s chronic lymphocytic leukemia treatment Imbruvica for reimbursement in June, but left the door open to further discussion.…
The European Medicines Agency recommendations for drug approvals saw a steady uptick in 2015, even as the number of new active substances fell slightly. Source: International Pharmaceutical Regulatory Monitor
France is tightening restrictions on early-phase clinical trials in the wake of one study that left one patient brain-dead and hospitalized five others. Source: International Pharmaceutical Regulatory Monitor
The European Union wants to expand ongoing trade talks between the U.S. and EU to address regulatory harmonization on drug approval requirements, guidelines and GMP compliance. Source: International Pharmaceutical Regulatory…
Italian regulatory authorities have cited two Indian drugmakers for dozens of GMP issues, ranging from data security to quality management issues. Source: International Pharmaceutical Regulatory Monitor
Indian API maker Dhanuka Laboratories could lose its EU GMP certificate after an inspection turned up 32 violations. Source: International Pharmaceutical Regulatory Monitor
The FDA has accused two foreign API makers of data integrity practices in recent warning letters. Source: International Pharmaceutical Regulatory Monitor
Industry groups are worried that a section of the proposed FDA and NIH Workforce Authorities Modernization Act would exempt biologics from adhering to U.S. Pharmacopeial standards for quality. Source: Generic…